• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用扩散加权磁共振成像和灌注加权磁共振成像鉴别良性与恶性脑膜瘤

Differentiation between benign and malignant meningiomas using diffusion and perfusion MR imaging.

作者信息

Todua F, Chedia S

机构信息

Radiology Department, Clinical Medicine Centre, Tbilisi, Georgia.

出版信息

Georgian Med News. 2012 May(206):16-22.

PMID:22870830
Abstract

The purpose of the study was to investigate the utility of diffusion-weighted (DW) and perfusion-weighted (PW) MR imaging to differentiate benign and malignant meningiomas which were verified histologically. A total of 29 patients with meningiomas (22 benign and 7 malignant) underwent conventional, perfusion and diffusion MR imaging. Conventional MRI revealed the ordinary signs of tumor. The absolute apparent diffusion coefficient (ADC) and normalized ADC (NADC) ratio, maximal relative cerebral blood volume (rCBV) and the corresponding relative mean time to enhance (rMTE) in both tumour parenchyma and peritumoral edema were measured. The mean ADC of malignant meningiomas (0.64±0.12 x 10(-3) mm(2)/s) was significantly lower compared with benign meningiomas (0.89±0.09 x 10(-3) mm(2)/s; P<.0001). Mean NADC ratio in the malignant group (0.93±0.18) was also significantly lower than in the benign group (1.29±0.12; P<.0001). The mean maximal rCBV values of benign and malignant meningiomas were 7.18±4.12 and 6.01±3.89, in the tumour parenchyma, and 1,07±0,95 and 3,85±1,41 in the peritumoral edema. The mean rMTE values were 1.14±0.23 and 1.24±0.27, in the tumour, and 0.88±0.24 and 1.21±0.31, in the peritumoral edema. The differences in rCBV and rMTE values between benign and malignant meningiomas were not significant (P>0.05) in the tumour parenchyma, but both were significant (p<0.05) in the peritumoral edema. Diffusion and perfusion MR imaging are useful in the preoperative differentiation between benign and malignant meningiomas.

摘要

本研究的目的是探讨扩散加权(DW)和灌注加权(PW)磁共振成像在鉴别经组织学证实的良性和恶性脑膜瘤中的应用价值。共有29例脑膜瘤患者(22例良性和7例恶性)接受了常规、灌注和扩散磁共振成像检查。常规MRI显示了肿瘤的常见征象。测量了肿瘤实质和瘤周水肿中的绝对表观扩散系数(ADC)和标准化ADC(NADC)比值、最大相对脑血容量(rCBV)以及相应的相对平均强化时间(rMTE)。恶性脑膜瘤的平均ADC(0.64±0.12×10⁻³mm²/s)显著低于良性脑膜瘤(0.89±0.09×10⁻³mm²/s;P<0.0001)。恶性组的平均NADC比值(0.93±0.18)也显著低于良性组(1.29±0.12;P<0.0001)。良性和恶性脑膜瘤在肿瘤实质中的平均最大rCBV值分别为7.18±4.12和6.01±3.89,在瘤周水肿中分别为1.07±0.95和3.85±1.41。平均rMTE值在肿瘤中分别为1.14±0.23和1.24±0.27,在瘤周水肿中分别为0.88±0.24和1.21±0.31。良性和恶性脑膜瘤在肿瘤实质中的rCBV和rMTE值差异无统计学意义(P>0.05),但在瘤周水肿中两者均有统计学意义(P<0.05)。扩散和灌注磁共振成像有助于术前鉴别良性和恶性脑膜瘤。

相似文献

1
Differentiation between benign and malignant meningiomas using diffusion and perfusion MR imaging.利用扩散加权磁共振成像和灌注加权磁共振成像鉴别良性与恶性脑膜瘤
Georgian Med News. 2012 May(206):16-22.
2
Perfusion MR imaging for differentiation of benign and malignant meningiomas.灌注磁共振成像用于鉴别良性和恶性脑膜瘤。
Neuroradiology. 2008 Jun;50(6):525-30. doi: 10.1007/s00234-008-0373-y. Epub 2008 Apr 1.
3
Correlating apparent diffusion coefficients with histopathologic findings on meningiomas.探讨脑膜瘤表观弥散系数与组织病理学表现的相关性。
Eur J Radiol. 2012 Dec;81(12):4050-6. doi: 10.1016/j.ejrad.2012.06.002. Epub 2012 Jun 22.
4
Quantitative apparent diffusion coefficients in the characterization of brain tumors and associated peritumoral edema.定量表观扩散系数在脑肿瘤及相关瘤周水肿特征描述中的应用
Acta Radiol. 2009 Jul;50(6):682-9. doi: 10.1080/02841850902933123.
5
Peritumoral brain regions in gliomas and meningiomas: investigation with isotropic diffusion-weighted MR imaging and diffusion-tensor MR imaging.胶质瘤和脑膜瘤周围脑区:采用各向同性扩散加权磁共振成像和扩散张量磁共振成像进行研究
Radiology. 2004 Aug;232(2):451-60. doi: 10.1148/radiol.2322030959. Epub 2004 Jun 23.
6
Diffusion-weighted MR imaging: diagnosing atypical or malignant meningiomas and detecting tumor dedifferentiation.扩散加权磁共振成像:诊断非典型或恶性脑膜瘤及检测肿瘤去分化
AJNR Am J Neuroradiol. 2008 Jun;29(6):1147-52. doi: 10.3174/ajnr.A0996. Epub 2008 Mar 20.
7
Role of MR Morphology and Diffusion-Weighted Imaging in the Evaluation of Meningiomas: Radio-Pathologic Correlation.磁共振成像形态学及扩散加权成像在脑膜瘤评估中的作用:放射病理相关性研究
JNMA J Nepal Med Assoc. 2019 Jan-Feb;57(215):37-44. doi: 10.31729/jnma.3968.
8
Is diffusion-weighted imaging useful in grading and differentiating histopathological subtypes of meningiomas?弥散加权成像在脑膜瘤的分级和鉴别组织病理学亚型方面是否有用?
Eur J Radiol. 2012 Sep;81(9):2389-95. doi: 10.1016/j.ejrad.2011.06.031. Epub 2011 Jul 1.
9
Comparison of ADC values of intracranial hemangiopericytomas and angiomatous and anaplastic meningiomas.颅内血管外皮细胞瘤与血管瘤型及间变性脑膜瘤的表观扩散系数(ADC)值比较。
J Neuroradiol. 2014 Jul;41(3):188-94. doi: 10.1016/j.neurad.2013.07.002. Epub 2014 Feb 10.
10
Differentiation of benign angiomatous and microcystic meningiomas with extensive peritumoral edema from high grade meningiomas with aid of diffusion weighted MRI.借助扩散加权磁共振成像鉴别伴有广泛瘤周水肿的良性血管瘤型和微囊型脑膜瘤与高级别脑膜瘤。
Biomed Res Int. 2014;2014:650939. doi: 10.1155/2014/650939. Epub 2014 Nov 16.

引用本文的文献

1
Diagnostic accuracy of diffusion weighted MRI in differentiating benign and malignant meningiomas.扩散加权磁共振成像在鉴别良性和恶性脑膜瘤中的诊断准确性
Pak J Med Sci. 2019;35(3):726-730. doi: 10.12669/pjms.35.3.1011.
2
Ability of F-FDG PET/CT Radiomic Features to Distinguish Breast Carcinoma from Breast Lymphoma.F-FDG PET/CT 影像组学特征鉴别乳腺癌与乳腺淋巴瘤的能力。
Contrast Media Mol Imaging. 2019 Feb 25;2019:4507694. doi: 10.1155/2019/4507694. eCollection 2019.
3
Distinguishing grade I meningioma from higher grade meningiomas without biopsy.
在不进行活检的情况下鉴别一级脑膜瘤与高级别脑膜瘤。
Oncotarget. 2015 Nov 10;6(35):38421-8. doi: 10.18632/oncotarget.5376.